Clinical Trial Update: Effects of Biktarvy on CFR in Stable HIV Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on Biktarvy showing effects on CFR in stable HIV patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: HIV | Phase 3 | Status: COMPLETED | Results posted: 2023-02-08